
Quarterly ResultNov 4, 2026, 04:14 PM
agilon health Q3 2026 Net Income $34.9M vs Loss $110.2M; Revenue $1.52B
AI Summary
agilon health, inc. reported its third-quarter financial results for 2026, showing a significant turnaround from the previous year. The company posted a net income of $34.9 million, or $2.08 per share, a substantial improvement from a net loss of $110.2 million, or ($6.65) per share, in the third quarter of 2025. Total revenues for the quarter increased by 5.8% to $1.519 billion. The balance sheet also reflects growth in total assets to $1.566 billion and an improvement in stockholders' equity to $280.9 million.
Key Highlights
- agilon health reported Q3 2026 revenue of $1.519B, a 5.8% increase from $1.435B in Q3 2025.
- Net income for Q3 2026 was $34.9M, a significant improvement from a net loss of $110.2M in Q3 2025.
- Basic EPS for Q3 2026 was $2.08, compared to a loss of ($6.65) in Q3 2025.
- Total assets increased to $1.566B as of September 30, 2026, from $1.271B as of December 31, 2025.
- Total liabilities increased to $1.285B as of September 30, 2026, from $1.145B as of December 31, 2025.
- Stockholders' equity (deficit) improved to $280.9M as of September 30, 2026, from $126.7M as of December 31, 2025.
Price Impact
More from AGL